Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,428 | -15,188 | -9,637 | -4,676 | -15,710 |
| Depreciation Amortization | 246 | 162 | 102 | 57 | 790 |
| Accounts receivable | 10 | 755 | 634 | 793 | -17 |
| Accounts payable and accrued liabilities | -181 | 1,667 | -123 | 78 | 12 |
| Other Working Capital | -2,866 | -676 | -2,472 | -1,210 | -1,010 |
| Other Operating Activity | 16,188 | 2,793 | 2,110 | 1,674 | 2,165 |
| Operating Cash Flow | $-7,031 | $-10,487 | $-9,386 | $-3,284 | $-13,770 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,081 | 5,197 | 3,346 | 1,145 | -4,492 |
| PPE Investments | -684 | -482 | -118 | -37 | -70 |
| Net Acquisitions | -238 | -251 | -244 | -236 | -3,820 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -358 |
| Investing Cash Flow | $4,159 | $4,464 | $2,984 | $872 | $-8,740 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -71 | -40 | -23 | -12 | -54 |
| Common Stock Issued | -165 | N/A | N/A | N/A | 27,735 |
| Other Financing Activity | 0 | -174 | -169 | -164 | 369 |
| Financing Cash Flow | $-236 | $-214 | $-192 | $-176 | $28,050 |
| Exchange Rate Effect | 1,734 | 1,593 | 906 | 96 | 80 |
| Beginning Cash Position | 13,409 | 13,409 | 13,409 | 13,409 | 8,170 |
| End Cash Position | 12,035 | 8,765 | 7,721 | 10,917 | 13,780 |
| Net Cash Flow | $-1,374 | $-4,644 | $-5,688 | $-2,492 | $5,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,031 | -10,487 | -9,386 | -3,284 | -13,770 |
| Capital Expenditure | -684 | -482 | -118 | -37 | -71 |
| Free Cash Flow | -7,715 | -10,969 | -9,504 | -3,321 | -13,841 |